Literature DB >> 3582718

Electrolyte composition of the amniotic fluid in Bartter syndrome.

G Massa, W Proesmans, H Devlieger, K Vandenberghe, A Van Assche, E Eggermont.   

Abstract

In three patients with neonatal Bartter syndrome associated with polyhydramnios, analysis of the amniotic fluid showed normal sodium, normal-to-low potassium, but high chloride concentrations. This finding clearly suggests a renal chloride reabsorption defect as the primary cause of the neonatal form of Bartter syndrome. It is suggested that whenever polyhydramnios occurs, the electrolyte composition of the amniotic fluid should first be analysed in order to establish the diagnosis of Bartter syndrome.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3582718     DOI: 10.1016/0028-2243(87)90159-6

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  5 in total

1.  Exogenous prostaglandin administration and pseudo-Bartter syndrome.

Authors:  J P Langhendries; V Thiry; E Bodart; G Delfosse; L Whitofs; O Battisti; J M Bertrand
Journal:  Eur J Pediatr       Date:  1989-12       Impact factor: 3.183

2.  Antenatal Bartter's syndrome with sensorineural deafness.

Authors:  R P Bhamkar; A Gajendragadkar
Journal:  Indian J Nephrol       Date:  2009-01

3.  Growth from birth to adulthood in a patient with the neonatal form of Bartter syndrome.

Authors:  W Proesmans; G Massa; M Vanderschueren-Lodeweyckx
Journal:  Pediatr Nephrol       Date:  1988-04       Impact factor: 3.714

4.  Antenatal bartter syndrome: a review.

Authors:  Y Ramesh Bhat; G Vinayaka; K Sreelakshmi
Journal:  Int J Pediatr       Date:  2012-02-28

5.  Heavy metal ion concentration in the amniotic fluid of preterm and term pregnancies from two cities with different industrial output.

Authors:  Radu Ionut Neamtu; Marius Craina; George Dahma; Alin Viorel Popescu; Adelina Geanina Erimescu; Ioana Citu; Amadeus Dobrescu; Florin George Horhat; Dan Dumitru Vulcanescu; Florin Gorun; Elena Silvia Bernad; Andrei Motoc; Ioan Cosmin Citu
Journal:  Exp Ther Med       Date:  2021-12-03       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.